BRPI0920069A8 - Biomarcadores - Google Patents
BiomarcadoresInfo
- Publication number
- BRPI0920069A8 BRPI0920069A8 BRPI0920069A BRPI0920069A BRPI0920069A8 BR PI0920069 A8 BRPI0920069 A8 BR PI0920069A8 BR PI0920069 A BRPI0920069 A BR PI0920069A BR PI0920069 A BRPI0920069 A BR PI0920069A BR PI0920069 A8 BRPI0920069 A8 BR PI0920069A8
- Authority
- BR
- Brazil
- Prior art keywords
- biomarkers
- suffered
- myocardial infarction
- increased risk
- identifying patients
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title abstract 2
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Primary Health Care (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10964908P | 2008-10-30 | 2008-10-30 | |
| PCT/EP2009/064410 WO2010049538A1 (en) | 2008-10-30 | 2009-10-30 | Biomarkers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0920069A2 BRPI0920069A2 (pt) | 2017-06-06 |
| BRPI0920069A8 true BRPI0920069A8 (pt) | 2017-10-03 |
Family
ID=41528764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0920069A BRPI0920069A8 (pt) | 2008-10-30 | 2009-10-30 | Biomarcadores |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20110294683A1 (enExample) |
| EP (1) | EP2362942B1 (enExample) |
| JP (1) | JP5749171B2 (enExample) |
| CN (1) | CN102203606A (enExample) |
| BR (1) | BRPI0920069A8 (enExample) |
| CA (1) | CA2741117A1 (enExample) |
| ES (1) | ES2640900T3 (enExample) |
| RU (1) | RU2545757C2 (enExample) |
| WO (1) | WO2010049538A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2012014268A (es) | 2010-07-09 | 2013-02-12 | Somalogic Inc | Biomarcadores de cancer de pulmon y usos de los mismos. |
| EP2603622A4 (en) | 2010-08-13 | 2015-04-22 | Somalogic Inc | BIOMARKERS FOR PANCREATIC CANCER AND USES THEREOF |
| EP2592422A1 (en) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment |
| EP2592423A1 (en) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment |
| JP2014207883A (ja) * | 2013-03-27 | 2014-11-06 | 国立大学法人岡山大学 | がん幹細胞及びその用途 |
| WO2014191553A2 (en) * | 2013-05-31 | 2014-12-04 | Cobiores Nv | Heart failure treatment |
| EP2843414B1 (en) | 2013-08-26 | 2018-09-19 | Roche Diagniostics GmbH | Marker for statin treatment stratification in heart failure |
| CN103487586B (zh) * | 2013-09-04 | 2015-07-15 | 石家庄洹众生物科技有限公司 | 一种定量检测可溶性生长刺激表达蛋白2的试验装置 |
| PL228091B1 (pl) * | 2014-02-12 | 2018-02-28 | Inst Biochemii I Biofizyki Polskiej Akademii Nauk | Zestaw biomarkerów transkryptomicznych do zastosowania w stratyfikacji indywidualnego ryzyka rozwoju pozawałowej niewydolnosci serca, sposób diagnozowania ryzyka wystapienia u pacjenta pozawałowej niewydolnosci serca i zastosowanie biomarkerów do diagnostyki in vitro |
| WO2015183601A1 (en) | 2014-05-28 | 2015-12-03 | Scripps Health | Predictive analysis for myocardial infarction |
| CN105243294B (zh) * | 2015-09-18 | 2017-06-09 | 淮南师范学院 | 一种用于预测癌症病人预后相关的蛋白质对的方法 |
| RU2634375C2 (ru) * | 2016-04-18 | 2017-10-26 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт кардиологии" | Способ предупреждения постинфарктного ремоделирования сердца в эксперименте |
| CA3030038A1 (en) * | 2016-07-06 | 2018-01-11 | Guardant Health, Inc. | Methods for fragmentome profiling of cell-free nucleic acids |
| DE102017116204B4 (de) * | 2017-07-18 | 2024-06-27 | Universität Rostock | Verfahren zur Vorhersage der Antwort auf die kardiovaskuläre Regeneration |
| US11708600B2 (en) * | 2017-10-05 | 2023-07-25 | Decode Health, Inc. | Long non-coding RNA gene expression signatures in disease diagnosis |
| JP2022549479A (ja) * | 2019-09-30 | 2022-11-25 | エフ．ホフマン－ラ ロシュ アーゲー | 疾患状態の予測方法 |
| JP7489059B2 (ja) * | 2020-04-21 | 2024-05-23 | 国立大学法人横浜国立大学 | 画像生成装置、表示装置、画像生成方法、提示方法およびプログラム |
| US11854675B1 (en) | 2022-10-11 | 2023-12-26 | Flatiron Health, Inc. | Machine learning extraction of clinical variable values for subjects from clinical record data |
| US11915807B1 (en) * | 2022-10-11 | 2024-02-27 | Flatiron Health, Inc. | Machine learning extraction of clinical variable values for subjects from clinical record data |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ513780A (en) * | 1999-03-03 | 2001-09-28 | Ludwig Inst Cancer Res | Heart abnormalities in vascular endothelial growth factor B (VEGF-B) deficient animals and methods relating to these heart abnormalities |
| CN1139811C (zh) * | 1999-11-09 | 2004-02-25 | 赵永同 | 肿瘤早期检测评估试剂盒及其制备工艺 |
| CN1260492A (zh) * | 1999-11-09 | 2000-07-19 | 赵永同 | 肿瘤预后评估试剂盒及其制备工艺 |
| ATE315789T1 (de) * | 1999-11-16 | 2006-02-15 | Genentech Inc | Elisa für vegf |
| CA2409948A1 (en) * | 2000-05-17 | 2001-11-22 | Xuri Li | Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents |
| WO2003000009A2 (en) * | 2001-06-20 | 2003-01-03 | Ludwig Institute For Cancer Research | Stimulation of vascularization with vegf-b |
| CN100401063C (zh) * | 2001-08-13 | 2008-07-09 | 遗传学发展股份有限公司 | 选择人类肿瘤最佳疗法的分子诊断和计算机决策辅助系统 |
| US20030096248A1 (en) * | 2001-09-04 | 2003-05-22 | Vitivity, Inc. | Diagnosis and treatment of vascular disease |
| US7435419B2 (en) * | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
| DE50309809D1 (de) * | 2002-11-16 | 2008-06-19 | Dade Behring Marburg Gmbh | Scd40l, papp-a und plazentaler-wachstumsfaktor (pigf) als biochemische markerkombinationen bei kardiovaskulären erkrankungen |
| US8632994B2 (en) * | 2003-12-01 | 2014-01-21 | Dako Denmark A/S | Methods and compositions for immuno-histochemical detection |
| CN101426489A (zh) * | 2004-04-16 | 2009-05-06 | 曹义海 | 抑制血管生成的成分和方法 |
| US20070037232A1 (en) * | 2005-03-31 | 2007-02-15 | Barasch Jonathan M | Detection of NGAL in chronic renal disease |
| TW200732347A (en) * | 2005-10-06 | 2007-09-01 | Trophogen Inc | VEGF analogs and methods of use |
-
2009
- 2009-10-30 BR BRPI0920069A patent/BRPI0920069A8/pt not_active IP Right Cessation
- 2009-10-30 US US12/998,543 patent/US20110294683A1/en not_active Abandoned
- 2009-10-30 EP EP09752320.3A patent/EP2362942B1/en not_active Not-in-force
- 2009-10-30 CA CA2741117A patent/CA2741117A1/en not_active Abandoned
- 2009-10-30 JP JP2011533750A patent/JP5749171B2/ja not_active Expired - Fee Related
- 2009-10-30 WO PCT/EP2009/064410 patent/WO2010049538A1/en not_active Ceased
- 2009-10-30 RU RU2011121613/15A patent/RU2545757C2/ru active
- 2009-10-30 ES ES09752320.3T patent/ES2640900T3/es active Active
- 2009-10-30 CN CN200980143296XA patent/CN102203606A/zh active Pending
-
2015
- 2015-09-22 US US14/861,506 patent/US20160188835A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012507026A (ja) | 2012-03-22 |
| CA2741117A1 (en) | 2010-05-06 |
| EP2362942B1 (en) | 2017-06-21 |
| RU2011121613A (ru) | 2012-12-10 |
| US20160188835A1 (en) | 2016-06-30 |
| CN102203606A (zh) | 2011-09-28 |
| RU2545757C2 (ru) | 2015-04-10 |
| EP2362942A1 (en) | 2011-09-07 |
| US20110294683A1 (en) | 2011-12-01 |
| WO2010049538A1 (en) | 2010-05-06 |
| ES2640900T3 (es) | 2017-11-07 |
| JP5749171B2 (ja) | 2015-07-15 |
| BRPI0920069A2 (pt) | 2017-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015015605A (es) | Biomarcadores para predecir y evaluar el grado de respuesta de sujetos con cancer de endometrio a compuestos de tipo lenvatinib. | |
| MX382403B (es) | Métodos para predecir el riesgo de desarrollar hipertensión. | |
| MX391175B (es) | Macrociclos peptidomimeticos. | |
| CY1121981T1 (el) | Μεθοδος για τον προσδιορισμο κινδυνου pml | |
| BR112012031389A2 (pt) | método para prever os resultados clínicos para pacientes com melanoma usando células de melanoma circulantes no sangue | |
| AR077026A1 (es) | Marcadores de riesgo para enfermedades cardiovasculares | |
| CR20110066A (es) | Anticuerpos monoclonales contra el factor tisular inhibidor de la via | |
| BR112012012513A2 (pt) | método para diagnosticar síndrome do intestino irritável em um paciente, método para monitorar a progressão ou regressão da síndrome do intestino irritável em um paciente, e para designar uma terapia contra síndrome do intestino irritável a um paciente em necessidade do mesmo | |
| EP3568451A4 (en) | PROCESSING BIOMASS WITH A HYDROGEN SOURCE | |
| ZA201104357B (en) | Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof | |
| PL2562268T3 (pl) | Nieinwazyjna diagnostyka aneuploidii płodu za pomocą sekwencjonowania | |
| EA201590024A1 (ru) | Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток | |
| BRPI0820557A2 (pt) | biomarcadores diagnósticos de diabetes | |
| HRP20150181T1 (hr) | Cd73 kao biomarker za praä†enje razvoja bolesti i procjenu uäśinkovitosti lijeäśenja | |
| BR112015008255A2 (pt) | método para o diagnóstico, prognóstico e tratamento de metástase de câncer de próstata | |
| CR20120453A (es) | Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfp) | |
| EP2715350A4 (en) | USE OF ACT PHOSPHORYLATION AS BIOMARKERS FOR THE PROGNOSIS OF NEURODEEGENERATIVE DISEASES AND THEIR TREATMENT | |
| EP2512219A4 (en) | COMBINED USE OF VIP3AB AND CRY1FA TO COMBAT RESISTANT INSECTS | |
| BR112012029985A2 (pt) | métodos de determinação de rotatividade beta-amiloide no sangue. | |
| EP2185174A4 (en) | METHOD OF USE OF TRIM72 AS A TARGET FOR MUSCLE AND HEART ENHANCER | |
| EP2585455A4 (en) | COMPOUNDS AND THEIR USE IN THE MODULATION OF THE CONCENTRATIONS OF VARIOUS AMYLOID BETA PEPTIDE ALLOYS | |
| BR112012032389A2 (pt) | biomarcadores para a previsão de câncer incidente | |
| MX377026B (es) | Biomarcadores para la progresión de enfermedades en melanoma. | |
| BR112014015575A8 (pt) | método para definir região de interesse em imagem de radiação de seio | |
| BR112014009223A2 (pt) | método para o diagnóstico da doença de niemann-pick |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: LUXEMBOURG INSTITUTE OF HEALTH (LU) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2486 DE 28-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |